Supply of Medicine and Medical / Surgical equipments : Tetanus Toxoid Adsorbed 0.5ml (single\ndose) Ampoule/vial\nAdsorbed Tetanus Vaccine BP single dose\n(0.5mL)\nOR\nTetanus Toxoid Adsorbed USP single dose\n(0.5mL)\nEach 0.5mL single dose ampoule/vial should\ncontain an estimated potency of not less than\n40 units of Tetanus Toxoid. The vaccine to\ncontain Tetanus Toxoid produced by the\ngrowth of Clostridum Tetani in the form of\nTetanus Formol Toxoid.\nNote:\n1. Offers should be only from vaccine suppliers\nrecommended by World Health Organization\nfor bulk purchase for U.N. Agencies (WHO pre-\nqualified).\n2. The following documents should be\nsubmitted pre- shipment for each lot of vaccine\ndispatched. (a)Invoice (b) Certificate of origin\n(c) Certificate of analysis (d)Lot release\ncertificate from National control\nLaboratory(NCL) from country of\norigin.(e)Summary lot protocols of production\nprocedure & quality control testing. These\ndocuments should be submitted pre-shipment\nto the National Control Laboratory for Vaccines\n(MRI) Sri Lanka.\n3. The product should be from fresh stocks and\neach consignment should be prepared\npreferably from a single batch.\n4. The product should have a minimum 2/3 of\nremaining shelf life at the time of delivery at\nMSD.\n5. The vaccine should also comply with the\ngeneral requirements for vaccines in the\nBP,USP or other pharmacopeial standards\napproved by NMRA, Sri Lanka.\n6. Cold Chain monitors or WHO recommended\nother cold chain monitoring device should be\nincluded for each carton and the cold chain etc .

STATE PHARMACEUTICALS CORPORATION OF SRI LANKA Sri Lanka has Released a tender for Supply of Medicine and Medical / Surgical equipments : Tetanus Toxoid Adsorbed 0.5ml (single\ndose) Ampoule/vial\nAdsorbed Tetanus Vaccine BP single dose\n(0.5mL)\nOR\nTetanus Toxoid Adsorbed USP single dose\n(0.5mL)\nEach 0.5mL single dose ampoule/vial should\ncontain an estimated potency of not less than\n40 units of Tetanus Toxoid. The vaccine to\ncontain Tetanus Toxoid produced by the\ngrowth of Clostridum Tetani in the form of\nTetanus Formol Toxoid.\nNote:\n1. Offers should be only from vaccine suppliers\nrecommended by World Health Organization\nfor bulk purchase for U.N. Agencies (WHO pre-\nqualified).\n2. The following documents should be\nsubmitted pre- shipment for each lot of vaccine\ndispatched. (a)Invoice (b) Certificate of origin\n(c) Certificate of analysis (d)Lot release\ncertificate from National control\nLaboratory(NCL) from country of\norigin.(e)Summary lot protocols of production\nprocedure & quality control testing. These\ndocuments should be submitted pre-shipment\nto the National Control Laboratory for Vaccines\n(MRI) Sri Lanka.\n3. The product should be from fresh stocks and\neach consignment should be prepared\npreferably from a single batch.\n4. The product should have a minimum 2/3 of\nremaining shelf life at the time of delivery at\nMSD.\n5. The vaccine should also comply with the\ngeneral requirements for vaccines in the\nBP,USP or other pharmacopeial standards\napproved by NMRA, Sri Lanka.\n6. Cold Chain monitors or WHO recommended\nother cold chain monitoring device should be\nincluded for each carton and the cold chain etc . in Pharmaceuticals. The tender was released on Mar 20, 2025.

Country - Sri Lanka

Summary - Supply of Medicine and Medical / Surgical equipments : Tetanus Toxoid Adsorbed 0.5ml (single\ndose) Ampoule/vial\nAdsorbed Tetanus Vaccine BP single dose\n(0.5mL)\nOR\nTetanus Toxoid Adsorbed USP single dose\n(0.5mL)\nEach 0.5mL single dose ampoule/vial should\ncontain an estimated potency of not less than\n40 units of Tetanus Toxoid. The vaccine to\ncontain Tetanus Toxoid produced by the\ngrowth of Clostridum Tetani in the form of\nTetanus Formol Toxoid.\nNote:\n1. Offers should be only from vaccine suppliers\nrecommended by World Health Organization\nfor bulk purchase for U.N. Agencies (WHO pre-\nqualified).\n2. The following documents should be\nsubmitted pre- shipment for each lot of vaccine\ndispatched. (a)Invoice (b) Certificate of origin\n(c) Certificate of analysis (d)Lot release\ncertificate from National control\nLaboratory(NCL) from country of\norigin.(e)Summary lot protocols of production\nprocedure & quality control testing. These\ndocuments should be submitted pre-shipment\nto the National Control Laboratory for Vaccines\n(MRI) Sri Lanka.\n3. The product should be from fresh stocks and\neach consignment should be prepared\npreferably from a single batch.\n4. The product should have a minimum 2/3 of\nremaining shelf life at the time of delivery at\nMSD.\n5. The vaccine should also comply with the\ngeneral requirements for vaccines in the\nBP,USP or other pharmacopeial standards\napproved by NMRA, Sri Lanka.\n6. Cold Chain monitors or WHO recommended\nother cold chain monitoring device should be\nincluded for each carton and the cold chain etc .

Deadline - Apr 30, 2025

MT reference number - 105339265

Product classification - Pharmaceutical products